DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

DNA of Entrepreneurs: Calculated Risk-taking and Bringing Game-changing Technology to the World

Session Chair(s)

Leslie J. Williams

Leslie J. Williams

Director, Founder, President and Chief Executive Officer

ImmusanT, United States

Being willing to take risk is essential to innovation, creativity and entrepreneurship. Calculated risk involves considerable analysis and market understanding but also requires passion, guts, perseverance, constant reassessment and willingness to change course.

Learning Objective : Define calculated risk; Describe potential road blocks to bringing a disruptive technology to the market; Outline key decisions that mitigate risk and allow you to advance in a capital-efficient manner; Describe traits of an entrepreneur and ways to promote the entrepreneurial spirit in the workplace.

Speaker(s)

Thomas  Hughes, PHD

A Tale of Two Pharmas

Thomas Hughes, PHD

Zafgen, Inc., United States

President and Chief Executive Officer

Leslie J. Williams

Build It and They Will Come, Won't They?

Leslie J. Williams

ImmusanT, United States

Director, Founder, President and Chief Executive Officer

Laurie A. Halloran, BSN, MS

Plans, People and Process: Outsourcing and Scaling Your Operations

Laurie A. Halloran, BSN, MS

United States

President and Chief Executive Officer

Walter  Ogier

Show Me the Money

Walter Ogier

Acetylon Pharmaceuticals, Inc., United States

Chief Executive Officer

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。